DIBAN CAP
DIBAN CAP
Discontinued
DIN Number
02041626
Drug Class
Human
Market Date
Feb 18, 1998
Company
HC
wyeth-ayerst canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02041626
AIG Number0602321001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
A07DA02 OPIUM
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:08.08
Health Canada Classification
ACTIVE INGREDIENTS (6)
ATROPINE SULFATEActive
Strength: 9.7 MCG
Monograph: ATROPINE SULFATE
ATTAPULGITE (ACTIVATED)Active
Strength: 300 MG
Monograph: ATTAPULGITE (ACTIVATED)
HYOSCYAMINE SULFATEActive
Strength: 0.0519 MG
Monograph: HYOSCYAMINE SULFATE
OPIUMActive
Strength: 12 MG
Monograph: OPIUM
PECTINActive
Strength: 71.4 MG
Monograph: PECTIN
SCOPOLAMINE HYDROBROMIDEActive
Strength: 3.3 MCG
Monograph: SCOPOLAMINE HYDROBROMIDE